Swiss National Bank Trims Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Swiss National Bank lessened its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 4.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 562,600 shares of the medical device company’s stock after selling 28,300 shares during the quarter. Swiss National Bank owned 0.28% of Cooper Companies worth $51,720,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Covestor Ltd increased its holdings in Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after buying an additional 200 shares during the period. GSA Capital Partners LLP lifted its stake in Cooper Companies by 150.6% during the 3rd quarter. GSA Capital Partners LLP now owns 6,993 shares of the medical device company’s stock valued at $772,000 after acquiring an additional 4,202 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its holdings in shares of Cooper Companies by 1.5% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 443,863 shares of the medical device company’s stock valued at $48,976,000 after acquiring an additional 6,489 shares during the last quarter. KBC Group NV increased its stake in shares of Cooper Companies by 5.1% in the third quarter. KBC Group NV now owns 258,460 shares of the medical device company’s stock worth $28,519,000 after acquiring an additional 12,435 shares during the period. Finally, Metis Global Partners LLC raised its holdings in shares of Cooper Companies by 3.8% during the third quarter. Metis Global Partners LLC now owns 15,982 shares of the medical device company’s stock worth $1,763,000 after purchasing an additional 583 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

COO opened at $81.22 on Friday. The firm’s fifty day simple moving average is $91.20 and its two-hundred day simple moving average is $98.90. The Cooper Companies, Inc. has a 52-week low of $77.05 and a 52-week high of $112.38. The company has a market cap of $16.24 billion, a price-to-earnings ratio of 41.65, a PEG ratio of 2.25 and a beta of 1.02. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.92. The firm had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Piper Sandler reaffirmed an “overweight” rating and issued a $115.00 price target (down from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Wells Fargo & Company upped their target price on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Morgan Stanley reduced their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. Citigroup lowered their price objective on Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Friday, March 7th. Finally, Stifel Nicolaus cut their target price on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a report on Friday, March 7th. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $111.89.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.